User Name:
Password:
Remember Login:
 
Forgot your password?
 
Or to join, click here.

 












BioHouston thanks our Associate Partners for their support!

Connected Solutions    Ernst & Young    FulBright & Jaworski L.L.P    Mayer Brown           

 
 
 
JOIN BIOHOUSTON

BioHouston is supported annually through corporate memberships.  Membership benefits are myriad—to view membership benefits and join, click here.
 
 
BIOHOUSTON RESOURCE CENTER

The BioHouston Resource Center (BRC) makes it easier and more affordable for start-up companies to get to work producing proof-of-concept data, by providing access to wet lab bench space, shared equipment, and the offices and tools that start-up companies need. For more information, click here.

Your support is needed—for more information, click here.
 
 
HIGHLIGHTS

 
Joe Cunningham, M.D., Managing Director, Santé Ventures
 
Prior to founding Santé Ventures, Dr. Cunningham was a healthcare venture partner with Austin Ventures and was previously the vice chair of the Ascension Health Ventures investment committee. He is also the former chief medical officer of the Providence Health System and executive director of the 300-physician Providence Health Alliance, both of which belong to the Ascension Health system. Dr. Cunningham currently serves as a member of the Board of Trustees of the Texas Medical Association and of the Medical Advisory Board of Blue Cross Blue Shield of Texas. He has extensive management experience and is recognized nationally for his expertise in healthcare delivery systems, physician associations and compensation models. He is board certified in both Internal Medicine and Quality Assurance and Peer Review.


Michael E. DeBakeryMichael E. DeBakey Life Science Award
 
OrthoAccel Technologies, Inc. was the winner of the 2007 Michael E. DeBakey Award and $25,000 cash prize. OrthoAccel Technologies, Inc. designs, develops, and markets a revolutionary device that cuts treatment time for braces in half and works in combination with all existing orthodontia bracket technologies. A panel of venture capitalists awarded OrthoAccel Technologies the DeBakey Life Science Award based on its exceptional potential in commercializing its technology. In addition to the $25,000 cash prize, OrthoAccel received a pro bono provisional patent filing from Baker & McKenzie LLP and premier visibility for the year in all BioHouston programs. To provide further support to the emerging companies that win this award, BioHouston offers winners low cost, short-term office space to help further close the funding gaps typically faced by these companies. OrthoAccel became our newest resident company at the beginning of 2008.
 
 
CURRENT BIOTECH NEWS

ULURU Inc. Announces the Launch Plan for Altrazeal(TM)

ArthroCare Announces Patients Treated for Chronic Tendinosis with TOPAZ(R) Highly Satisfied Study Shows

LC Sciences and DNAVision form Strategic Marketing Alliance

Kinetic Concepts, Inc. Closes Private Sale of Convertible Senior Notes Due 2015 Pursuant to Full Exercise of Over-Allotment Option Lexicon and BioSeek to Work Together on Drug Discovery

ArthroCare(R) Establishes Direct Sales Representation in Scandinavia

ThromboVision's New Director of Engineering Brings Biotech and Design Background

Lexicon and BioSeek to Work Together on Drug Discovery

IDev Technologies Closes $25 Million Financing Round

Asuragen Launches The First Validated microRNA Diagnostic Assay

Asuragen Launches Signature(R) LTx (Leukemia Translocation Panel) Globally

Agennix Initiates a Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis

Lexicon's Drug Candidate for Rheumatoid Arthritis, LX2931, Shows Positive Results in Phase 1 Clinical Trial

Introgen Therapeutics, Inc. Expands Board of Directors

Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms

Opexa Therapeutics Presents Tovaxin Phase I/II Data at the American Academy of Neurology 60th Annual Meeting

Lexicon Presents Clinical Data for LX6171, a Drug Candidate for Cognitive Disorders

Kinetic Concepts, Inc. to Offer $600M Convertible Notes to Acquire LifeCell Corporation

SeqWright Expands Next Generation Lineup with the Addition of 454’s GS FLX(TM) System

Alcon Announces Plans to Build Pharmaceutical Manufacturing Plant in Singapore

Power3 Medical Products Receives CLIA Compliance Recertification

Introgen's New Phase III Data Confirm Phase II Findings of ADVEXIN(R) Efficacy

Tanox's AIDS Drug Survives


 
 
Participants will learn about market opportunities, intellectual property issues, life science business plans, sources of funding, and the successful launch and management of a life science start-up.
  
 
BioHouston Breakfast Forum - May 14, 2008
The Early Stages of Venture Capital in Texas
Joe Cunningham, M.D., Managing Director, Santé Ventures
Sponsored by Mayer Brown LLP

 
Save the date! Sponsorship opportunities available...please contact Keisha Curtis at 713.979.9212.
 


Purchase the 2007/2008 Life Science directory
 
BioHouston